Recent News

• 12.18.2025 - Thérapeutique Knight annonce l’obtention de l’autorisation de Santé Canada pour WYNZORA® pour le traitement du psoriasis vulgaris
• 12.18.2025 - Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris

Recent Filings

• 12.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.12.2025 - 8-K Current report
• 12.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 12.11.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.08.2025 - 8-K Current report
• 12.08.2025 - EX-99.1 EX-99.1